FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Andreas von Deimling

Research Profile

Disorders

Physiology

Phenomena

Polymorphism, Single-Stranded Conformational

Chemicals & Drugs

Procedures

Genes & Molecular Sequences

Anatomy

Co-author Network

Publications

TOP 3
Matthias Preusser; Sebastian F Schoppmann; Berthold Streubel; Andreas von Deimling; Georg Widhalm; Adelheid Wöhrer; Christoph C Zielinski; Sabine Zöchbauer-Müller; Karin Dieckmann; Carina Dinhof; Monika Hackl; Ayseguel Ilhan-Mutlu; Manuel Magerle; Christine Marosi; Anna S Berghoff; Peter Birner
ALK gene translocations and amplifications in brain metastases of non-small cell lung cancer.
Leonille Schweizer; Matthias Simon; Otmar D Wiestler; Albert Becker; David Capper; Tanja Göck; Antje Habel; Stephanie Heim; Christel Herold-Mende; David T W Jones; Christian Koelsche; Rainer König; Christian Mawrin; Gunhild Mechtersheimer; Jochen Meyer; Werner Paulus; Stefan M Pfister; Rosario Michael Piro; Stefan Pusch; David E Reuss; Felix Sahm; Jens Schittenhelm; Andreas von Deimling
Meningeal hemangiopericytoma and solitary fibrous tumors carry the NAB2-STAT6 fusion and can be diagnosed by nuclear expression of STAT6 protein.
Ulrike Lass; Maren Meiboom; David Capper; Christian Hartmann; Christel Herold-Mende; Andreas von Deimling; Wolf Mueller
Chromogenic in situ Hybridization is a Reliable Alternative to Fluorescence in situ Hybridization for Diagnostic Testing of 1p and 19q Loss in Paraffin-Embedded Gliomas.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Andreas von Deimling (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Matthias Preusser; Sebastian F Schoppmann; Berthold Streubel; Andreas von Deimling; Georg Widhalm; Adelheid Wöhrer; Christoph C Zielinski; Sabine Zöchbauer-Müller; Karin Dieckmann; Carina Dinhof; Monika Hackl; Ayseguel Ilhan-Mutlu; Manuel Magerle; Christine Marosi; Anna S Berghoff; Peter Birner
ALK gene translocations and amplifications in brain metastases of non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2013;80(3):278-83.
2013: Leonille Schweizer; Matthias Simon; Otmar D Wiestler; Albert Becker; David Capper; Tanja Göck; Antje Habel; Stephanie Heim; Christel Herold-Mende; David T W Jones; Christian Koelsche; Rainer König; Christian Mawrin; Gunhild Mechtersheimer; Jochen Meyer; Werner Paulus; Stefan M Pfister; Rosario Michael Piro; Stefan Pusch; David E Reuss; Felix Sahm; Jens Schittenhelm; Andreas von Deimling
Meningeal hemangiopericytoma and solitary fibrous tumors carry the NAB2-STAT6 fusion and can be diagnosed by nuclear expression of STAT6 protein.
Acta neuropathologica 2013;125(5):651-8.
2013: Ulrike Lass; Maren Meiboom; David Capper; Christian Hartmann; Christel Herold-Mende; Andreas von Deimling; Wolf Mueller
Chromogenic in situ Hybridization is a Reliable Alternative to Fluorescence in situ Hybridization for Diagnostic Testing of 1p and 19q Loss in Paraffin-Embedded Gliomas.
Brain pathology (Zurich, Switzerland) 2013;23(3):311-8.
2013: Matthias Preusser; Sebastian F Schoppmann; Andreas von Deimling; Anna S Berghoff; David Capper; Carina Dinhof; Michael Hejna; Aysegül Ilhan-Mutlu; Manuel Magerle; Christine Marosi; Peter Birner
Brain metastases of gastro-oesophageal cancer: evaluation of molecules with relevance for targeted therapies.
Anticancer research 2013;33(3):1065-71.
2013: Barbara Klink; Rupavathana Mahesparan; Hrvoje Miletic; Simone P Niclou; Mads Aarhus; Jörg Balss; Rolf Bjerkvig; Peter C Huszthy; Lars Kaderali; Per Øystein Sakariassen; Evelin Schröck; Manja Schubert; Daniel Stieber; Terje Sundstrøm; Anja Torsvik; Jaime Alberto Campos Valenzuela; Andreas von Deimling; Jian Wang; Janice M Nigro
A novel, diffusely infiltrative xenograft model of human anaplastic oligodendroglioma with mutations in FUBP1, CIC, and IDH1.
PloS one 2013;8(3):e59773.
2012: Andrey Korshunov; Jan Koster; Peter Lichter; Paul A Northcott; Arie Perry; Stefan Pfister; Daniel Picard; Marc Rosenblum; Marina Ryzhova; Ulrich Schüller; Peter van Sluis; Rogier Versteeg; Richard Volckmann; Andreas von Deimling; Eleonora Aronica; V Peter Collins; Cynthia Cowdrey; Felice Giangaspero; Martin Hasselblatt; Annie Huang; David T W Jones; Marcel Kool
LIN28A immunoreactivity is a potent diagnostic marker of embryonal tumor with multilayered rosettes (ETMR).
Acta neuropathologica 2012;124(6):875-81.
2012: Jörg Balss; Ann-Christin Beck; Wolfgang Buckel; Christel Herold-Mende; Alwin Krämer; Claus-Dieter Langhans; Jürgen G Okun; Stefan Pusch; Christian Thiede; Andreas von Deimling
Enzymatic assay for quantitative analysis of (D)-2-hydroxyglutarate.
Acta neuropathologica 2012;124(6):883-91.
2012: Benito Campos; Jittiporn Chaisaingmongkol; Lea Geiselhart; Christian Hartmann; Christoph Plass; Odilia Popanda; Peter Schmezer; Andreas Unterberg; Andreas von Deimling; Rolf Warta; Christel Herold-Mende
Epigenetically mediated downregulation of the differentiation-promoting chaperon protein CRABP2 in astrocytic gliomas.
International journal of cancer. Journal international du cancer 2012;131(8):1963-8.
2012: Felix Sahm; Marion Schneider; Albrecht Stenzinger; Ioannis Anagnostopoulos; Anna-Sophie Berghoff; David Capper; Antje Habel; Andreas Kulozik; Felix Lasitschka; Gunhild Mechtersheimer; Jochen Meyer; Leonhard Müllauer; Matthias Preusser; Andreas von Deimling
BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis.
Blood 2012;120(12):e28-34.
2012: Andreas von Deimling; Felix Sahm; David Capper
Mutation specific antibodies: tool or dinosaur?
Oncotarget 2012;3(9):907-8.
2012: Alexander Skorokhod; Andreas von Deimling; David Capper; Alexander Enk; Peter Helmbold
Detection of BRAF V600E mutations in skin metastases of malignant melanoma by monoclonal antibody VE1.
Journal of the American Academy of Dermatology 2012;67(3):488-91.
2012: Rezvan Ahmadi; Natalia Becker; David Capper; Arne Christians; Christine Dictus; Christel Herold-Mende; Katarina Hohlen; Martin Misch; Florian Stockhammer; Andreas Unterberg; Andreas von Deimling; Wolfgang Wick; Christian Hartmann
No prognostic value of IDH1 mutations in a series of 100 WHO grade II astrocytomas.
Journal of neuro-oncology 2012;109(1):15-22.
2012: David Capper; Christian Hartmann; Claus-Dieter Langhans; Jürgen G Okun; Matthias Simon; Jörg C Tonn; Andreas von Deimling; Michael Weller
2-Hydroxyglutarate concentration in serum from patients with gliomas does not correlate with IDH1/2 mutation status or tumor size.
International journal of cancer. Journal international du cancer 2012;131(3):766-8.
2012: Sebastian Adeberg; Jürgen Debus; Daniel Habermehl; Christian Hartmann; Stefan Rieken; Andreas von Deimling; Thomas Welzel; Stephanie E Combs
Long-term outcome after radiotherapy in patients with atypical and malignant meningiomas--clinical results in 85 patients treated in a single institution leading to optimized guidelines for early radiation therapy.
International journal of radiation oncology, biology, physics 2012;83(3):859-64.
2012: Oskar Koperek; Christoph Kornauth; Bruno Niederle; Reza Asari; Anna Sophie Berghoff; Peter Birner; David Capper; Andreas von Deimling; Matthias Preusser
Immunohistochemical detection of the BRAF V600E-mutated protein in papillary thyroid carcinoma.
The American journal of surgical pathology 2012;36(6):844-50.
2012: Felix Sahm; Andreas von Deimling; Christel Herold-Mende; Christian Koelsche; Kerstin Lindenberg; Jochen Meyer; Wolf Mueller; Stefan Pusch; Christian Hartmann
CIC and FUBP1 mutations in oligodendrogliomas, oligoastrocytomas and astrocytomas.
Acta neuropathologica 2012;123(6):853-60.
2012: Florian Stockhammer; Andreas von Deimling; Hans-Joachim Helms; Ulrike Lengler; Martin Misch; Friedrich Prall; Christian Hartmann
IDH1/2 mutations in WHO grade II astrocytomas associated with localization and seizure as the initial symptom.
Seizure : the journal of the British Epilepsy Association 2012;21(3):194-7.
2012: Andrey Korshunov; Andreas E Kulozik; Peter Lichter; Paul A Northcott; V Peter Collins; Elke Pfaff; Axel Benner; Yoon-Jae Cho; Steven C Clifford; Thomas Hielscher; David T W Jones; Marcel Kool; Marc Remke; Marina Ryzhova; Wolfram Scheurlen; Michael D Taylor; Andreas von Deimling; William A Weiss; Frank Westermann; Dan Williamson; Hendrik Witt; Andrea Wittmann; Stefan M Pfister
Biological and clinical heterogeneity of MYCN-amplified medulloblastoma.
Acta neuropathologica 2012;123(4):515-27.
2012: David Capper; Antje Habel; Monika Hackl; Aysegül Ilhan; Manuel Magerle; Jochen Meyer; peter petzelbauer; Josef Pichler; Anna Sophie Berghoff; Peter Birner; Stefan Pusch; Andreas von Deimling; Adelheid Wöhrer; Matthias Preusser
Immunohistochemical testing of BRAF V600E status in 1,120 tumor tissue samples of patients with brain metastases.
Acta neuropathologica 2012;123(2):223-33.
2012: Maren Bradtmöller; Anja Harder; Christian Hartmann; Frank L Heppner; Sebastian Jäschke; Andreas Kurtz; Victor-Felix Mautner; Su-Jin Park; David Reuss; Andreas von Deimling; Jan Zietsch; Michael Baier; Nikola Holtkamp
Impaired Pten expression in human malignant peripheral nerve sheath tumours.
PloS one 2012;7(11):e47595.
2012: Ulrike Lass; Christel Herold-Mende; Jörn A Horaczek; Judith W M Jeuken; Jürgen Kiwit; Astrid Nümann; Florian Stockhammer; Julian Veelken; Andreas von Deimling; Kajetan von Eckardstein; Wolf Mueller
Clonal analysis in recurrent astrocytic, oligoastrocytic and oligodendroglial tumors implicates IDH1- mutation as common tumor initiating event.
PloS one 2012;7(7):e41298.
2012: Arne Christians; Christian Hartmann; Jochen Meyer; Andreas von Deimling; Michael Weller; Wolfgang Wick; Axel Benner; Markus Weiler
Prognostic value of three different methods of MGMT promoter methylation analysis in a prospective trial on newly diagnosed glioblastoma.
PloS one 2012;7(3):e33449.
2011: Stephanie E Combs; Jürgen Debus; Daniela Schulz-Ertner; Andreas von Deimling; Christian Hartmann
Improved correlation of the neuropathologic classification according to adapted world health organization classification and outcome after radiotherapy in patients with atypical and anaplastic meningiomas.
International journal of radiation oncology, biology, physics 2011;81(5):1415-21.
2011: Till Milde; Ina Oehme; Stefan M Pfister; Andreas von Deimling; Hendrik Witt; Axel Benner; Oliver Brüstle; Hedwig E Deubzer; Richard J Gilbertson; Hermann-Josef Gröne; Thomas Hielscher; Manfred Jugold; Susanne Kleber; Philipp Koch; Hans-Georg Kopp; Andrey Korshunov; Andreas E Kulozik; Marco Lodrini; Ana Martin Villalba; Olaf Witt
A novel human high-risk ependymoma stem cell model reveals the differentiation-inducing potential of the histone deacetylase inhibitor Vorinostat.
Acta neuropathologica 2011;122(5):637-50.
2011: Christiane A. Opitz; Martina Ott; Gilles J Guillemin; Leonie Jestaedt; Manfred Jugold; Irina Lehmann; Ulrike M Litzenburger; Christian Lutz; Christine L Miller; Bernhard Radlwimmer; Felix Sahm; Dieter Schrenk; Theresa Schumacher; Isabel Tritschler; Saskia Trump; Andreas von Deimling; Michael Weller; Wolfgang Wick; Michael Platten
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor.
Nature 2011;478(7368):197-203.
2011: Marc Remke; Stefan Rutkowski; Marina Ryzhova; Wolfram Scheurlen; Anna Schöttler; Dominik Sturm; Michael D Taylor; Grischa Toedt; André O von Bueren; Andreas von Deimling; Frank Westermann; Hendrik Witt; Andrea Wittmann; Sebastian Bender; Axel Benner; Huriye Cin; Daniel Haag; Thomas Hielscher; Marcel Kool; Andrey Korshunov; Andreas E Kulozik; Peter Lichter; Paul A Northcott; Stefan Pfister
FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(29):3852-61.
2011: Michael Weller; Wolfgang Wick; Andreas von Deimling
Isocitrate dehydrogenase mutations: a challenge to traditional views on the genesis and malignant progression of gliomas.
Glia 2011;59(8):1200-4.
2011: Christian Hartmann; Bettina Hentschel; Markus Loeffler; Torsten Pietsch; Guido Reifenberger; Oliver Schnell; Johannes Schramm; Clemens Seidel; Robert Stein; Marcos Tatagiba; Andreas von Deimling; Michael Weller
Molecular markers in low-grade gliomas: predictive or prognostic?
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(13):4588-99.
2011: Jennifer Lohr; Thomas Ratliff; Andreas Unterberg; Andreas von Deimling; Nobuyoshi Hiraoka; Andrea Huppertz; Thomas Korff; Rezvan Ahmadi; Philipp Beckhove; Christine Dictus; Rupert C Ecker; Volker Eckstein; Yingzi Ge; Stefan Grau; Christel Herold-Mende
Effector T-cell infiltration positively impacts survival of glioblastoma patients and is impaired by tumor-derived TGF-β.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(13):4296-308.
2011: Huriye Cin; Claus Meyer; Ricarda Herr; Wibke G Janzarik; Sally Lambert; David T W Jones; Karine Jacob; Axel Benner; Hendrik Witt; Marc Remke; Sebastian Bender; Fabian Falkenstein; Ton Nu Van Anh; Heike Olbrich; Andreas von Deimling; Arnulf Pekrun; Andreas E Kulozik; Astrid Gnekow; Wolfram Scheurlen; Olaf Witt; Heymut Omran; Nada Jabado; V Peter Collins; Tilman Brummer; Rolf Marschalek; Peter Lichter; Andrey Korshunov; Stefan Pfister
Oncogenic FAM131B-BRAF fusion resulting from 7q34 deletion comprises an alternative mechanism of MAPK pathway activation in pilocytic astrocytoma.
Acta neuropathologica 2011;121(6):763-74.
2011: Anja Elstner; Florian Stockhammer; Trong-Nghia Nguyen-Dobinsky; Quang Long Nguyen; Ingo Pilgermann; Amanjit Gill; Anke Guhr; Tingguo Zhang; Kajetan von Eckardstein; Thomas Picht; Julian Veelken; Robert L Martuza; Andreas von Deimling; Andreas Kurtz
Identification of diagnostic serum protein profiles of glioblastoma patients.
Journal of neuro-oncology 2011;102(1):71-80.
2011: Grischa Toedt; Sebastian Barbus; Marietta Wolter; Jörg Felsberg; Björn Tews; Frederic Blond; Michael C Sabel; Stefanie Hofmann; Natalia Becker; Christian Hartmann; Hiroko Ohgaki; Andreas von Deimling; Otmar D Wiestler; Meinhard Hahn; Peter Lichter; Guido Reifenberger; Bernhard Radlwimmer
Molecular signatures classify astrocytic gliomas by IDH1 mutation status.
International journal of cancer. Journal international du cancer 2011;128(5):1095-103.
2011: Stephanie E Combs; Jürgen Debus; Stefan Rieken; Andreas von Deimling; Wolfgang Wick; Amir Abdollahi; Christian Hartmann
Prognostic significance of IDH-1 and MGMT in patients with glioblastoma: one step forward, and one step back?
Radiation oncology (London, England) 2011;6():115.
2011: Subhash Thalappilly; Matthias Truss; Andreas von Deimling; Xiaolan Feng; Daniel Larocque; Daniel Muruve; Svitlana Pastyryeva; Karl Riabowol; Stephane Richard; Keiko Suzuki; Gesche Tallen
The p53 tumor suppressor is stabilized by inhibitor of growth 1 (ING1) by blocking polyubiquitination.
PloS one 2011;6(6):e21065.
2010: Benjamin Berger; David Capper; Dieter Lemke; Philipp-Niclas Pfenning; Michael Platten; Michael Weller; Andreas von Deimling; Wolfgang Wick; Markus Weiler
Defective p53 antiangiogenic signaling in glioblastoma.
Neuro-oncology 2010;12(9):894-907.
2010: Andrey Korshunov; Marc Remke; Marco Gessi; Marina Ryzhova; Thomas Hielscher; Hendrik Witt; Vivienne Tobias; Anna Maria Buccoliero; Iacopo Sardi; Marina Paola Gardiman; Jose Bonnin; Bernd Scheithauer; Andreas E Kulozik; Olaf Witt; Sverre Mork; Andreas von Deimling; Otmar D Wiestler; Felice Giangaspero; Marc K Rosenblum; Torsten Pietsch; Peter Lichter; Stefan Pfister
Focal genomic amplification at 19q13.42 comprises a powerful diagnostic marker for embryonal tumors with ependymoblastic rosettes.
Acta neuropathologica 2010;120(2):253-60.
2010: Markus Weiler; Christian Hartmann; Dorothee Wiewrodt; Ulrich Herrlinger; Thierry Gorlia; Oliver Bähr; Richard Meyermann; D D; Marcos Tatagiba; Andreas von Deimling; Michael Weller; Wolfgang Wick
Chemoradiotherapy of newly diagnosed glioblastoma with intensified temozolomide.
International journal of radiation oncology, biology, physics 2010;77(3):670-6.
2010: Till Milde; Ina Oehme; Andrey Korshunov; Annette Kopp-Schneider; Marc Remke; Paul Northcott; Hedwig E Deubzer; Marco Lodrini; Michael D Taylor; Andreas von Deimling; Stefan Pfister; Olaf Witt
HDAC5 and HDAC9 in medulloblastoma: novel markers for risk stratification and role in tumor cell growth.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(12):3240-52.
2010: Maria Demestre; Jan Herzberg; Nikola Holtkamp; Christian Hagel; David Reuss; Reinhard E Friedrich; Lan Kluwe; Andreas von Deimling; Victor-Felix Mautner; Andreas Kurtz
Imatinib mesylate (Glivec) inhibits Schwann cell viability and reduces the size of human plexiform neurofibroma in a xenograft model.
Journal of neuro-oncology 2010;98(1):11-9.
2010: Stephanie E Combs; Christian Hartmann; Anna Nikoghosyan; Oliver Jäkel; Christian P Karger; Thomas Haberer; Andreas von Deimling; Marc W Münter; Peter E Huber; Jürgen Debus; Daniela Schulz-Ertner
Carbon ion radiation therapy for high-risk meningiomas.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2010;95(1):54-9.
2010: Maria Lueth; Andreas von Deimling; Torsten Pietsch; Lee-Jun Wong; Andreas Kurtz; Guenter Henze; Pablo Hernáiz Driever
Medulloblastoma harbor somatic mitochondrial DNA mutations in the D-loop region.
Journal of pediatric hematology/oncology 2010;32(2):156-9.
2010: Jochen Meyer; Stefan Pusch; Jörg Balss; David Capper; Wolf Mueller; Arne Christians; Christian Hartmann; Andreas von Deimling
PCR- and restriction endonuclease-based detection of IDH1 mutations.
Brain pathology (Zurich, Switzerland) 2010;20(2):298-300.
2010: Jan Zietsch; Nicolas Ziegenhagen; Frank L Heppner; David Reuss; Andreas von Deimling; Nikola Holtkamp
The 4q12 amplicon in malignant peripheral nerve sheath tumors: consequences on gene expression and implications for sunitinib treatment.
PloS one 2010;5(7):e11858.
2010: Mona Tamannai; Sonja Farhangi; Matthias Truss; Brigitte Sinn; Reinhard Wurm; Pinaki Bose; Guenter Henze; Karl Riabowol; Andreas von Deimling; Gesche Tallen
The inhibitor of growth 1 (ING1) is involved in trichostatin A-induced apoptosis and caspase 3 signaling in p53-deficient glioblastoma cells.
Oncology research 2010;18(10):469-80.
2009: Wolfgang Wick; Christian Hartmann; Corinna Engel; Mandy Stoffels; Jörg Felsberg; Florian Stockhammer; Michael C Sabel; Susanne Koeppen; Ralf Ketter; Richard Meyermann; Marion Rapp; Christoph Meisner; Rolf-Dieter Kortmann; Torsten Pietsch; Otmar D Wiestler; Ulrike Ernemann; D D; Guido Reifenberger; Andreas von Deimling; Michael Weller
NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(35):5874-80.
2009: Helena Nord; Christian Hartmann; Robin Andersson; Uwe Menzel; Susan Pfeifer; Arkadiusz Piotrowski; Adam Bogdan; Wojciech Kloc; Johanna Sandgren; Tommie Olofsson; Göran Hesselager; Erik Blomquist; Jan Komorowski; Andreas von Deimling; Carl E G Bruder; Jan P Dumanski; Teresita Díaz de Ståhl
Characterization of novel and complex genomic aberrations in glioblastoma using a 32K BAC array.
Neuro-oncology 2009;11(6):803-18.
2009: Maria Lueth; Lena Wronski; Almut Giese; Renate Kirschner-Schwabe; Torsten Pietsch; Andreas von Deimling; Günter Henze; Andreas Kurtz; Pablo Hernáiz Driever
Somatic mitochondrial mutations in pilocytic astrocytoma.
Cancer genetics and cytogenetics 2009;192(1):30-5.
2009: Juliane Rieber; Marc Remke; Christian Hartmann; Andrey Korshunov; Birgit Burkhardt; Dominik Sturm; Gunhild Mechtersheimer; Andrea Wittmann; Johann Greil; Claudia Blattmann; Olaf Witt; Wolfgang Behnisch; Marc-Eric Halatsch; Berk Orakcioglu; Andreas von Deimling; Peter Lichter; Andreas E Kulozik; Stefan Pfister
Novel oncogene amplifications in tumors from a family with Li-Fraumeni syndrome.
Genes, chromosomes & cancer 2009;48(7):558-68.
2009: David Capper; Timo Gaiser; Christian Hartmann; Antje Habel; Wolf Mueller; Christel Herold-Mende; Andreas von Deimling; Markus David Siegelin
Stem-cell-like glioma cells are resistant to TRAIL/Apo2L and exhibit down-regulation of caspase-8 by promoter methylation.
Acta neuropathologica 2009;117(4):445-56.
2009: Stefan Pfister; Marc Remke; Mirco Castoldi; Alfa H C Bai; Martina U Muckenthaler; Andreas Kulozik; Andreas von Deimling; Armin Pscherer; Peter Lichter; Andrey Korshunov
Novel genomic amplification targeting the microRNA cluster at 19q13.42 in a pediatric embryonal tumor with abundant neuropil and true rosettes.
Acta neuropathologica 2009;117(4):457-64.
2009: Markus D Siegelin; David E Reuss; Antje Habel; Abdelhaq Rami; Andreas von Deimling
Quercetin promotes degradation of survivin and thereby enhances death-receptor-mediated apoptosis in glioma cells.
Neuro-oncology 2009;11(2):122-31.
2009: Aiala Lorente; Wolf Mueller; Edurne Urdangarín; Paula Lázcoz; Ulrike Lass; Andreas von Deimling; Javier S Castresana
RASSF1A, BLU, NORE1A, PTEN and MGMT expression and promoter methylation in gliomas and glioma cell lines and evidence of deregulated expression of de novo DNMTs.
Brain pathology (Zurich, Switzerland) 2009;19(2):279-92.
2009: Till Milde; Stefan Pfister; Andrey Korshunov; Hedwig E Deubzer; Ina Oehme; Aurélie Ernst; Anna Starzinski-Powitz; Angelika Seitz; Peter Lichter; Andreas von Deimling; Olaf Witt
Stepwise accumulation of distinct genomic aberrations in a patient with progressively metastasizing ependymoma.
Genes, chromosomes & cancer 2009;48(3):229-38.
2009: Gesche Tallen; Sonja Farhangi; Mona Tamannai; Nikola Holtkamp; Dorothea Mangoldt; Sitar Shah; Keiko Suzuki; Matthias Truss; Guenter Henze; Karl Riabowol; Andreas von Deimling
The inhibitor of growth 1 (ING1) proteins suppress angiogenesis and differentially regulate angiopoietin expression in glioblastoma cells.
Oncology research 2009;18(2-3):95-105.
2009: Florian Stockhammer; Andreas von Deimling; Frank K H van Landeghem
Decreased expression of the active subunit of the cystine/glutamate antiporter xCT is associated with loss of heterozygosity of 1p in oligodendroglial tumours WHO grade II.
Histopathology 2009;54(2):241-7.
2009: Ina Oehme; Hedwig E Deubzer; Dennis Wegener; Diana Pickert; Jan-Peter Linke; Barbara Hero; Annette Kopp-Schneider; Frank Westermann; Scott M Ulrich; Andreas von Deimling; Matthias Fischer; Olaf Witt
Histone deacetylase 8 in neuroblastoma tumorigenesis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(1):91-9.
2009: Frank K H van Landeghem; K Maier-Hauff; A Jordan; Karl-Titus Hoffmann; U Gneveckow; R Scholz; B Thiesen; W Brück; Andreas von Deimling
Post-mortem studies in glioblastoma patients treated with thermotherapy using magnetic nanoparticles.
Biomaterials 2009;30(1):52-7.
2008: Jörg Balss; Jochen Meyer; Wolf Mueller; Andrey Korshunov; Christian Hartmann; Andreas von Deimling
Analysis of the IDH1 codon 132 mutation in brain tumors.
Acta neuropathologica 2008;116(6):597-602.
2008: Markus D Siegelin; David E Reuss; Antje Habel; Christel Herold-Mende; Andreas von Deimling
The flavonoid kaempferol sensitizes human glioma cells to TRAIL-mediated apoptosis by proteasomal degradation of survivin.
Molecular cancer therapeutics 2008;7(11):3566-74.
2008: Florian Stockhammer; Andreas von Deimling; Michael Synowitz; Cristiane Blechschmidt; Frank K H van Landeghem
Expression of glucose transporter 1 is associated with loss of heterozygosity of chromosome 1p in oligodendroglial tumors WHO grade II.
Journal of molecular histology 2008;39(5):553-60.
2008: Andrey Korshunov; Axel Benner; Marc Remke; Peter Lichter; Andreas von Deimling; Stefan Pfister
Accumulation of genomic aberrations during clinical progression of medulloblastoma.
Acta neuropathologica 2008;116(4):383-90.
2008: Ana Martin Villalba; Ali Fuat Okuducu; Andreas von Deimling
The evolution of our understanding on glioma.
Brain pathology (Zurich, Switzerland) 2008;18(3):455-63.
2008: Susanne Kleber; Ignacio Sancho-Martinez; Benedict Wiestler; Alexandra Beisel; Christian Gieffers; Oliver Hill; Meinolf Thiemann; Wolf Mueller; Jaromir Sykora; Andreas Kuhn; Nina Schreglmann; Elisabeth Letellier; Cecilia Zuliani; Stefan Klussmann; Marcin Teodorczyk; Hermann-Josef Gröne; Tom M Ganten; Holger Sültmann; Jochen Tüttenberg; Andreas von Deimling; Anne Regnier-Vigouroux; Christel Herold-Mende; Ana Martin Villalba
Yes and PI3K bind CD95 to signal invasion of glioblastoma.
Cancer cell 2008;13(3):235-48.
2008: Aiala Lorente; Wolf Mueller; Edurne Urdangarín; Paula Lázcoz; Andreas von Deimling; Javier S Castresana
Detection of methylation in promoter sequences by melting curve analysis-based semiquantitative real time PCR.
BMC cancer 2008;8():61.
2008: Ute Gesche Tallen; Matthias Truss; Frank Kunitz; Sven Wellmann; Brad Unryn; Brigitte Sinn; Ulrike Lass; Sonja Krabbe; Nikola Holtkamp; Christian Hagemeier; Reinhard Wurm; Guenter Henze; Karl Riabowol; Andreas von Deimling
Down-regulation of the inhibitor of growth 1 (ING1) tumor suppressor sensitizes p53-deficient glioblastoma cells to cisplatin-induced cell death.
Journal of neuro-oncology 2008;86(1):23-30.
2007: Friederike Blankenburg; Frank K H van Landeghem; Michail Plotkin; Günter Henze; Andreas von Deimling; Pablo Hernáiz Driever
Occurrence of a spinal anaplastic pilocytic astrocytoma and a supratentorial PNET in an adolescent.
Journal of pediatric hematology/oncology 2007;29(12):832-5.
2007: Michael Weller; Hilmar Berger; Christian Hartmann; Johannes Schramm; Manfred Westphal; Matthias Simon; Roland Goldbrunner; Dietmar Krex; Joachim P Steinbach; Christoph B Ostertag; Markus Loeffler; Torsten Pietsch; Andreas von Deimling
Combined 1p/19q loss in oligodendroglial tumors: predictive or prognostic biomarker?
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(23):6933-7.
2007: Dietmar Krex; Barbara Klink; Christian Hartmann; Andreas von Deimling; Torsten Pietsch; Matthias Simon; Michael S Sabel; Joachim P Steinbach; Oliver Heese; Guido Reifenberger; Michael Weller; Gabriele Schackert
Long-term survival with glioblastoma multiforme.
Brain : a journal of neurology 2007;130(Pt 10):2596-606.
2007: Annegret Kunitz; Marietta Wolter; Jörg van den Boom; Jörg Felsberg; Björn Tews; Meinhard Hahn; Axel Benner; Michael S Sabel; Peter Lichter; Guido Reifenberger; Andreas von Deimling; Christian Hartmann
DNA hypermethylation and aberrant expression of the EMP3 gene at 19q13.3 in Human Gliomas.
Brain pathology (Zurich, Switzerland) 2007;17(4):363-70.
2007: Nikola Holtkamp; Isis Atallah; Ali Fuat Okuducu; Jana Mucha; Christian Hartmann; Victor-Felix Mautner; Reinhard E Friedrich; Christian Mawrin; Andreas von Deimling
MMP-13 and p53 in the progression of malignant peripheral nerve sheath tumors.
Neoplasia (New York, N.Y.) 2007;9(8):671-7.
2007: Frank K H van Landeghem; Thorsten Weiss; Andreas von Deimling
Expression of PACAP and glutamate transporter proteins in satellite oligodendrocytes of the human CNS.
Regulatory peptides 2007;142(1-2):52-9.
2007: Nikola Holtkamp; Nicolas Ziegenhagen; Elke Malzer; Christian Hartmann; Alf Giese; Andreas von Deimling
Characterization of the amplicon on chromosomal segment 4q12 in glioblastoma multiforme.
Neuro-oncology 2007;9(3):291-7.
2007: Frank K H van Landeghem; Thorsten Weiss; Manfred Oehmichen; Andreas von Deimling
Cellular localization of pituitary adenylate cyclase-activating peptide (PACAP) following traumatic brain injury in humans.
Acta neuropathologica 2007;113(6):683-93.
2007: Wolf Mueller; Gerd-Helge Schneider; Karl T Hoffmann; Rolf Zschenderlein; Andreas von Deimling
Granulomatous tissue response in germinoma, a diagnostic pitfall in endoscopic biopsy.
Neuropathology : official journal of the Japanese Society of Neuropathology 2007;27(2):127-32.
2007: Florian Stockhammer; Ulrich-Wilhelm Thomale; Michail Plotkin; Christian Hartmann; Andreas von Deimling
Association between fluorine-18-labeled fluorodeoxyglucose uptake and 1p and 19q loss of heterozygosity in World Health Organization Grade II gliomas.
Journal of neurosurgery 2007;106(4):633-7.
2007: Christian Hagel; Ulrich Zils; Matthias Peiper; Lan Kluwe; Stefan Gotthard; Reinhard E Friedrich; David Zurakowski; Andreas von Deimling; Victor-Felix Mautner
Histopathology and clinical outcome of NF1-associated vs. sporadic malignant peripheral nerve sheath tumors.
Journal of neuro-oncology 2007;82(2):187-92.
2007: Ingmar Blümcke; Elisabeth Pauli; Hans Clusmann; Johannes Schramm; Albert Becker; Christian Elger; Martin Merschhemke; Heinz-Joachim Meencke; Thomas Lehmann; Andreas von Deimling; Christian Scheiwe; Josef Zentner; Benedikt Volk; Johann Romstöck; Hermann Stefan; Michelle Hildebrandt
A new clinico-pathological classification system for mesial temporal sclerosis.
Acta neuropathologica 2007;113(3):235-44.
2007: W Mueller; Catherine L Nutt; Mathias Ehrich; M J Riemenschneider; Andreas von Deimling; Dirk van den Boom; David N Louis
Downregulation of RUNX3 and TES by hypermethylation in glioblastoma.
Oncogene 2007;26(4):583-93.
2007: Anja Elstner; Nikola Holtkamp; Andreas von Deimling
Involvement of Hif-1 in desferrioxamine-induced invasion of glioblastoma cells.
Clinical & experimental metastasis 2007;24(1):57-66.
2007: Klaus Maier-Hauff; Ronny Rothe; Regina Scholz; Uwe Gneveckow; Peter Wust; Burghard Thiesen; Annelie Feussner; Andreas von Deimling; Norbert Waldoefner; Roland Felix; Andreas Jordan
Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: results of a feasibility study on patients with glioblastoma multiforme.
Journal of neuro-oncology 2007;81(1):53-60.
2006: Frank K H van Landeghem; Thorsten Weiss; Manfred Oehmichen; Andreas von Deimling
Decreased expression of glutamate transporters in astrocytes after human traumatic brain injury.
Journal of neurotrauma 2006;23(10):1518-28.
2006: Ali Fuat Okuducu; Ulrich Zils; Silké A M Michaelis; Christian Mawrin; Andreas von Deimling
Increased expression of avian erythroblastosis virus E26 oncogene homolog 1 in World Health Organization grade 1 meningiomas is associated with an elevated risk of recurrence and is correlated with the expression of its target genes matrix metalloproteinase-2 and MMP-9.
Cancer 2006;107(6):1365-72.
2006: Björn Tews; Jörg Felsberg; Christian Hartmann; Annegret Kunitz; Meinhard Hahn; Grischa Toedt; Kai Neben; Lars Hummerich; Andreas von Deimling; Guido Reifenberger; Peter Lichter
Identification of novel oligodendroglioma-associated candidate tumor suppressor genes in 1p36 and 19q13 using microarray-based expression profiling.
International journal of cancer. Journal international du cancer 2006;119(4):792-800.
2006: Ali Fuat Okuducu; U Zils; Silké A M Michaelis; S Michaelides; Andreas von Deimling
Ets-1 is up-regulated together with its target gene products matrix metalloproteinase-2 and matrix metalloproteinase-9 in atypical and anaplastic meningiomas.
Histopathology 2006;48(7):836-45.
2006: Andreas Jordan; Regina Scholz; Klaus Maier-Hauff; Frank K H van Landeghem; Norbert Waldoefner; Ulf Teichgraeber; Jens Pinkernelle; Harald Bruhn; Fabian Neumann; Burghard Thiesen; Andreas von Deimling; Roland Felix
The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma.
Journal of neuro-oncology 2006;78(1):7-14.
2006: C Hartmann; L Devermann; Claire Gehlhaar; Nikola Holtkamp; Andreas von Deimling
PIK3CA mutations in oligodendroglial tumours.
Neuropathology and applied neurobiology 2006;32(2):209-12.
2006: Winfried Brenner; Reinhard E Friedrich; Karim A Gawad; Christian Hagel; Andreas von Deimling; Maike de Wit; Ralph Buchert; Malte Clausen; Victor-Felix Mautner
Prognostic relevance of FDG PET in patients with neurofibromatosis type-1 and malignant peripheral nerve sheath tumours.
European journal of nuclear medicine and molecular imaging 2006;33(4):428-32.
2006: Nikola Holtkamp; Ali Fuat Okuducu; Jana Mucha; Anastasia Afanasieva; Christian Hartmann; Isis Atallah; Lope Estevez-Schwarz; Christian Mawrin; Reinhard E Friedrich; Victor-Felix Mautner; Andreas von Deimling
Mutation and expression of PDGFRA and KIT in malignant peripheral nerve sheath tumors, and its implications for imatinib sensitivity.
Carcinogenesis 2006;27(3):664-71.
2006: Heike Biebermann; Tamara R Castañeda; Frank K H van Landeghem; Andreas von Deimling; Frederike Escher; Georg Brabant; Johannes Hebebrand; Anke Hinney; Matthias H Tschöp; Annette Grüters; Heiko Krude
A role for beta-melanocyte-stimulating hormone in human body-weight regulation.
Cell metabolism 2006;3(2):141-6.
2006: Wolf Mueller; Ulrike Lass; Julian Veelken; Friedrich Reuter; Andreas von Deimling
45-year-old male with symptomatic mass in the frontal lobe.
Brain pathology (Zurich, Switzerland) 2006;16(1):89-90, 93.
2006: Christian Hartmann; Jennifer Sieberns; Claire Gehlhaar; Matthias Simon; Werner Paulus; Andreas von Deimling
NF2 mutations in secretory and other rare variants of meningiomas.
Brain pathology (Zurich, Switzerland) 2006;16(1):15-9.
2005: Nikola Holtkamp; Anastasia Afanasieva; Anja Elstner; Frank K H van Landeghem; Matthias Könneker; Susanne A Kuhn; Helmut Kettenmann; Andreas von Deimling
Brain slice invasion model reveals genes differentially regulated in glioma invasion.
Biochemical and biophysical research communications 2005;336(4):1227-33.
2005: Silke Wemmert; Ralf Ketter; Jörg Rahnenführer; Niko Beerenwinkel; Martin Strowitzki; Wolfgang Feiden; Christian Hartmann; Thomas Lengauer; Florian Stockhammer; Klaus D Zang; Eckart Meese; Wolf-Ingo Steudel; Andreas von Deimling; Steffi Urbschat
Patients with high-grade gliomas harboring deletions of chromosomes 9p and 10q benefit from temozolomide treatment.
Neoplasia (New York, N.Y.) 2005;7(10):883-93.
2005: Rouslan Kotchetkov; Pablo Hernáiz Driever; Jindrich Cinatl; Martin Michaelis; Jana Karaskova; Roman A Blaheta; Jeremy A Squire; Andreas von Deimling; Jussi Moog; Jindrich Cinatl
Increased malignant behavior in neuroblastoma cells with acquired multi-drug resistance does not depend on P-gp expression.
International journal of oncology 2005;27(4):1029-37.
2005: Teresita Díaz de Ståhl; Christian Hartmann; Cecilia De Bustos; Arkadiusz Piotrowski; Magdalena Benetkiewicz; Kiran K Mantripragada; Tomasz Tykwinski; Andreas von Deimling; Jan P Dumanski
Chromosome 22 tiling-path array-CGH analysis identifies germ-line- and tumor-specific aberrations in patients with glioblastoma multiforme.
Genes, chromosomes & cancer 2005;44(2):161-9.
2005: Georg Bohner; Florian Masuhr; Roland Distl; Juri Katchanov; Randolf Klingebiel; Rolf Zschenderlein; Andreas von Deimling; Frank K H van Landeghem
Pilocytic astrocytoma presenting as primary diffuse leptomeningeal gliomatosis: report of a unique case and review of the literature.
Acta neuropathologica 2005;110(3):306-11.
2005: Christian Hartmann; Andreas von Deimling
Oligodendrogliomas: impact of molecular genetics on treatment.
Neurology India 2005;53(2):140-8.
2005: Christian Mawrin; Thomas Schneider; Raimund Firsching; Falk R Wiedemann; Knut Dietzmann; Antje Bornemann; Bernd F.M. Romeike; Bernd Sellhaus; Andreas von Deimling
Assessment of tumor cell invasion factors in gliomatosis cerebri.
Journal of neuro-oncology 2005;73(2):109-15.
2005: Christian Hartmann; Gesine Bartels; Claire Gehlhaar; Nikola Holtkamp; Andreas von Deimling
PIK3CA mutations in glioblastoma multiforme.
Acta neuropathologica 2005;109(6):639-42.
2005: Manuel Montesinos-Rongen; Roland Schmitz; Cornelius Courts; Werner Stenzel; Dörte Bechtel; Gerald Niedobitek; Ingmar Blümcke; Guido Reifenberger; Andreas von Deimling; Berit Jungnickel; Otmar D Wiestler; Ralf Küppers; Martina Deckert
Absence of immunoglobulin class switch in primary lymphomas of the central nervous system.
The American journal of pathology 2005;166(6):1773-9.
2005: Jörg Rahnenführer; Niko Beerenwinkel; Wolfgang A Schulz; Christian Hartmann; Andreas von Deimling; Bernd Wullich; Thomas Lengauer
Estimating cancer survival and clinical outcome based on genetic tumor progression scores.
Bioinformatics (Oxford, England) 2005;21(10):2438-46.
2005: Ali Fuat Okuducu; Jens Claus Hahne; Andreas von Deimling; Nicolas Wernert
Laser-assisted microdissection, techniques and applications in pathology (review).
International journal of molecular medicine 2005;15(5):763-9.
2005: Wolf Mueller; Ulrike Lass; Sven Wellmann; Frank Kunitz; Andreas von Deimling
Mutation analysis of DKK1 and in vivo evidence of predominant p53-independent DKK1 function in gliomas.
Acta neuropathologica 2005;109(3):314-20.
2005: Silké A M Michaelis; Ali Fuat Okuducu; Nanette M E Sarioglu; Andreas von Deimling; Joachim W Dudenhausen
The transcription factor Ets-1 is expressed in human amniochorionic membranes and is up-regulated in term and preterm premature rupture of membranes.
Journal of perinatal medicine 2005;33(4):314-9.
2005: Christian Hartmann; Wolf Mueller; Ulrike Lass; Suzanne Kamel-Reid; Andreas von Deimling
Molecular genetic analysis of oligodendroglial tumors.
Journal of neuropathology and experimental neurology 2005;64(1):10-4.
2004: Christian Hartmann; Xiudan Xu; Gesine Bartels; Nikola Holtkamp; Isis Atallah Gonzales; Gesche Tallen; Andreas von Deimling
Pdgfr-alpha in 1p/19q LOH oligodendrogliomas.
International journal of cancer. Journal international du cancer 2004;112(6):1081-2.
2004: Anja Harder; M Rosche; D E Reuss; Nikola Holtkamp; Karen Uhlmann; R Friedrich; Victor-Felix Mautner; Andreas von Deimling
Methylation analysis of the neurofibromatosis type 1 (NF1) promoter in peripheral nerve sheath tumours.
European journal of cancer (Oxford, England : 1990) 2004;40(18):2820-8.
2004: Judith W M Jeuken; Andreas von Deimling; Pieter Wesseling
Molecular pathogenesis of oligodendroglial tumors.
Journal of neuro-oncology 2004;70(2):161-81.
2004: Christian Hartmann; Wolf Mueller; Andreas von Deimling
Pathology and molecular genetics of oligodendroglial tumors.
Journal of molecular medicine (Berlin, Germany) 2004;82(10):638-55.
2004: Maximilian Posch; Chuanbing Zang; Wolf Mueller; Ulrike Lass; Andreas von Deimling; Elena Elstner
Somatic mutations in peroxisome proliferator-activated receptor-gamma are rare events in human cancer cells.
Medical science monitor : international medical journal of experimental and clinical research 2004;10(8):BR250-4.
2004: Nikola Holtkamp; David E Reuss; Isis Atallah; Ralf-Jürgen Kuban; Christian Hartmann; Victor-Felix Mautner; Silke Frahm; Reinhard E Friedrich; Bernd Algermissen; Van-Anh Pham; sandra prietz; Thorsten Rosenbaum; Lope Estevez-Schwarz; Andreas von Deimling
Subclassification of nerve sheath tumors by gene expression profiling.
Brain pathology (Zurich, Switzerland) 2004;14(3):258-64.
2004: W Mueller; J-H David Eum; Ulrike Lass; W Paulus; C Sarkar; W Bruck; Andreas von Deimling
No evidence of hSNF5/INI1 point mutations in choroid plexus papilloma.
Neuropathology and applied neurobiology 2004;30(3):304-7.
2004: Gesche Tallen; Ines Kaiser; Sonja Krabbe; Ulrike Lass; Christian Hartmann; Günter Henze; Karl Riabowol; Andreas von Deimling
No ING1 mutations in human brain tumours but reduced expression in high malignancy grades of astrocytoma.
International journal of cancer. Journal international du cancer 2004;109(3):476-9.
2004: Christian Hartmann; Astrid Nümann; Wolf Mueller; Nikola Holtkamp; Matthias Simon; Andreas von Deimling
Fine mapping of chromosome 22q tumor suppressor gene candidate regions in astrocytoma.
International journal of cancer. Journal international du cancer 2004;108(6):839-44.
2004: Meena Upadhyaya; Song Han; Claudia Consoli; Elisa Majounie; Martin Horan; Nick S Thomas; Christopher Potts; Sian Griffiths; Martino Ruggieri; Andreas von Deimling; David N Cooper
Characterization of the somatic mutational spectrum of the neurofibromatosis type 1 (NF1) gene in neurofibromatosis patients with benign and malignant tumors.
Human mutation 2004;23(2):134-46.
2004: Nikola Holtkamp; Victor-Felix Mautner; Reinhard E Friedrich; Anja Harder; Christian Hartmann; Agota Theallier-Janko; Karl T Hoffmann; Andreas von Deimling
Differentially expressed genes in neurofibromatosis 1-associated neurofibromas and malignant peripheral nerve sheath tumors.
Acta neuropathologica 2004;107(2):159-68.
2003: Frank K H van Landeghem; Stefan Schreiber; Andreas W Unterberg; Andreas von Deimling; John F Stover
Differential concentration-dependent effects of prolonged norepinephrine infusion on intraparenchymal hemorrhage and cortical contusion in brain-injured rats.
Journal of neurotrauma 2003;20(12):1327-37.
2003: Chuanbing Zang; Marlies Wächter; Hongyu Liu; Maximilian Posch; Martin Fenner; Christine Stadelmann; Andreas von Deimling; Kurt Possinger; Keith L Black; H Phillip Koeffler; Elena Elstner
Ligands for PPARgamma and RAR cause induction of growth inhibition and apoptosis in human glioblastomas.
Journal of neuro-oncology 2003;65(2):107-18.
2003: Stephen B Hunter; Daniel J Brat; Jeffrey J Olson; Andreas von Deimling; Wei Zhou; Erwin Van Meir
Alterations in molecular pathways of diffusely infiltrating glial neoplasms: application to tumor classification and anti-tumor therapy (Review).
International journal of oncology 2003;23(4):857-69.
2003: Kerstin Rhiem; Annette Klein; Miriam Münch; Rene Kreutzfeld; Juliane Ramser; Eva Wardelmann; Gabriele Schackert; Andreas von Deimling; Otmar D Wiestler; Rita K Schmutzler
Chromosomal region 15q21.1 is a frequent target of allelic imbalance in advanced breast carcinomas.
International journal of cancer. Journal international du cancer 2003;106(1):74-7.
2003: Christian Hartmann; Wolf Mueller; Ulrike Lass; Florian Stockhammer; Kajetan von Eckardstein; Julian Veelken; Judith W M Jeuken; Wolfgang Wick; Andreas von Deimling
No preferential loss of paternal 19q alleles in oligodendroglial tumors.
Annals of neurology 2003;54(2):256-8.
2003: Christian Mawrin; Elmar Kirches; Regine Schneider-Stock; Cordula Scherlach; Christian K Vorwerk; Andreas von Deimling; Frank K H van Landeghem; Richard Meyermann; Antje Bornemann; Andreas Müller; Bernd F.M. Romeike; Gisela Stoltenburg-Didinger; Jürgen Wickboldt; Peter Pilz; Knut Dietzmann
Analysis of TP53 and PTEN in gliomatosis cerebri.
Acta neuropathologica 2003;105(6):529-36.
2003: Catherine L Nutt; D R Mani; Rebecca A Betensky; Pablo Tamayo; J Gregory Cairncross; Christine Ladd; Ute Pohl; Christian Hartmann; Margaret E McLaughlin; Tracy T Batchelor; Peter Black; Andreas von Deimling; Scott L Pomeroy; Todd R Golub; David N Louis
Gene expression-based classification of malignant gliomas correlates better with survival than histological classification.
Cancer research 2003;63(7):1602-7.
2002: Kerstin Kaulich; Britta Blaschke; Astrid Nümann; Andreas von Deimling; Otmar D Wiestler; Ruthild G Weber; Guido Reifenberger
Genetic alterations commonly found in diffusely infiltrating cerebral gliomas are rare or absent in pleomorphic xanthoastrocytomas.
Journal of neuropathology and experimental neurology 2002;61(12):1092-9.
2002: Jan Mollenhauer; Hanna Müller; Gaby Kollender; Stefan Lyer; Laura Diedrichs; Burkhard Helmke; Uffe Holmskov; Toon Ligtenberg; Stephan Herbertz; Inge Krebs; Jens Madsen; Floris J Bikker; Liane Schmitt; Stefan Wiemann; Wolfram Scheurlen; Herwart F Otto; Andreas von Deimling; Annemarie Poustka
The SRCR/SID region of DMBT1 defines a complex multi-allele system representing the major basis for its variability in cancer.
Genes, chromosomes & cancer 2002;35(3):242-55.
2002: Wolf Mueller; Jan Mollenhauer; Florian Stockhammer; Annemarie Poustka; Andreas von Deimling
Rare mutations of the DMBT1 gene in human astrocytic gliomas.
Oncogene 2002;21(38):5956-9.
2002: Wolf Mueller; Christian Hartmann; Annegret Hoffmann; Wolfgang R. Lanksch; Juergen Kiwit; Jörg Tonn; Julian Veelken; Johannes Schramm; Michael Weller; Otmar D Wiestler; David N Louis; Andreas von Deimling
Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsets.
The American journal of pathology 2002;161(1):313-9.
2002: Karl L Kiening; Frank K H van Landeghem; Stefan Schreiber; Ulrich-Wilhelm Thomale; Andreas von Deimling; Andreas W Unterberg; John F Stover
Decreased hemispheric Aquaporin-4 is linked to evolving brain edema following controlled cortical impact injury in rats.
Neuroscience letters 2002;324(2):105-8.
2002: Matthias C Schmidt; Sven Antweiler; Nina Urban; Wolf Mueller; A Kuklik; Birgit Meyer-Puttlitz; Otmar D Wiestler; David N Louis; Rolf Fimmers; Andreas von Deimling
Impact of genotype and morphology on the prognosis of glioblastoma.
Journal of neuropathology and experimental neurology 2002;61(4):321-8.
2002: Heiko Krude; Barbara Schütz; Heike Biebermann; Arpad von Moers; Dirk Schnabel; Heidemarie Neitzel; Holger Tönnies; Dagmar Weise; Antony Lafferty; Siegfried Schwarz; Mario DeFelice; Andreas von Deimling; Frank K H van Landeghem; Roberto DiLauro; Annette Grüters
Choreoathetosis, hypothyroidism, and pulmonary alterations due to human NKX2-1 haploinsufficiency.
The Journal of clinical investigation 2002;109(4):475-80.
2001: T Joachim; Zvi Ram; Z Harry Rappaport; Matthias Simon; Johannes Schramm; Otmar D Wiestler; Andreas von Deimling
Comparative analysis of the NF2, TP53, PTEN, KRAS, NRAS and HRAS genes in sporadic and radiation-induced human meningiomas.
International journal of cancer. Journal international du cancer 2001;94(2):218-21.
2001: R Przkora; Birgit Meyer-Puttlitz; Ottmar Schmitt; Frank Berthold; Markus M Nöthen; J Krauss; Jörg-Christian Tonn; Andreas von Deimling; Otmar D Wiestler; Torsten Pietsch
Analysis of the TSC2 gene in human medulloblastoma.
Acta neuropathologica 2001;102(4):380-4.
2001: Frank K H van Landeghem; J F Stover; I Bechmann; W Brück; A Unterberg; C Bührer; Andreas von Deimling
Early expression of glutamate transporter proteins in ramified microglia after controlled cortical impact injury in the rat.
Glia 2001;35(3):167-79.
2001: Jürgen A Kraus; W de Millas; Niels Sörensen; C Herbold; Christian Schichor; Jörg-Christian Tonn; Otmar D Wiestler; Andreas von Deimling; Torsten Pietsch
Indications for a tumor suppressor gene at 22q11 involved in the pathogenesis of ependymal tumors and distinct from hSNF5/INI1.
Acta neuropathologica 2001;102(1):69-74.
2001: Jürgen A Kraus; Matthias Wenghoefer; N Glesmann; S Mohr; M Beck; Matthias C Schmidt; R Schröder; U Berweiler; W Roggendorf; Sabine Diete; Knut Dietzmann; K Heuser; B Müller; Rolf Fimmers; Andreas von Deimling; Uwe Schlegel
TP53 gene mutations, nuclear p53 accumulation, expression of Waf/p21, Bcl-2, and CD95 (APO-1/Fas) proteins are not prognostic factors in de novo glioblastoma multiforme.
Journal of neuro-oncology 2001;52(3):263-72.
2001: Albert J Becker; M Löbach; H Klein; Sabine Normann; Markus M Nöthen; Andreas von Deimling; M Mizuguchi; Christian E Elger; Johannes Schramm; Otmar D Wiestler; Ingmar Blümcke
Mutational analysis of TSC1 and TSC2 genes in gangliogliomas.
Neuropathology and applied neurobiology 2001;27(2):105-14.
2001: U Schmitz; W Mueller; M Weber; Nicolas Sévenet; Olivier Delattre; Andreas von Deimling
INI1 mutations in meningiomas at a potential hotspot in exon 9.
British journal of cancer 2001;84(2):199-201.
2001: Wolf Mueller; Ulrike Lass; J Herms; K Kuchelmeister; M Bergmann; Andreas von Deimling
Clonal analysis in glioblastoma with epithelial differentiation.
Brain pathology (Zurich, Switzerland) 2001;11(1):39-43.
2000: Lee Parry; Julie Maynard; A Patel; Angela K Hodges; Andreas von Deimling; Julian R Sampson; Jeremy P Cheadle
Molecular analysis of the TSC1 and TSC2 tumour suppressor genes in sporadic glial and glioneuronal tumours.
Human genetics 2000;107(4):350-6.
2000: Iver Petersen; Alfredo Hidalgo-Miranda; Simone Petersen; Karsten Schlüns; Christiane Schewe; Manuela Pacyna-Gengelbach; Almut Goeze; B Krebber; Thomas Knösel; Olaf Kaufmann; Janusz Szymas; Andreas von Deimling
Chromosomal imbalances in brain metastases of solid tumors.
Brain pathology (Zurich, Switzerland) 2000;10(3):395-401.
2000: Jürgen A Kraus; Matthias Wenghoefer; Matthias C Schmidt; Andreas von Deimling; U Berweiler; W Roggendorf; Sabine Diete; Knut Dietzmann; B Müller; K Heuser; Guido Reifenberger; Uwe Schlegel
Long-term survival of glioblastoma multiforme: importance of histopathological reevaluation.
Journal of neurology 2000;247(6):455-60.
2000: Anatol Kivi; Thomas-Nicolas Lehmann; Richard Kovács; Alexander Eilers; Regina Jauch; Heinz-Joachim Meencke; Andreas von Deimling; Uwe Heinemann; Siegrun Gabriel
Effects of barium on stimulus-induced rises of [K+]o in human epileptic non-sclerotic and sclerotic hippocampal area CA1.
The European journal of neuroscience 2000;12(6):2039-48.
2000: Andreas von Deimling; Rolf Fimmers; Matthias C Schmidt; B Bender; F Fassbender; J Nagel; R Jahnke; P Kaskel; EM Duerr; J Koopmann; D Maintz; S Steinbeck; W Wick; Michael Platten; D J Müller; R Przkora; Andreas Waha; B Blümcke; Ruth Wellenreuther; Birgit Meyer-Puttlitz; O Schmidt; J Mollenhauer; A Poustka; AP Stangl; Doris Lenartz; K von Ammon
Comprehensive allelotype and genetic anaysis of 466 human nervous system tumors.
Journal of neuropathology and experimental neurology 2000;59(6):544-58.
2000: Yasushi Ino; Magdalena C Zlatescu; Hikaru Sasaki; David R Macdonald; Anat Stemmer-Rachamimov; Sarah Jhung; David A Ramsay; Andreas von Deimling; David N Louis; J Gregory Cairncross
Long survival and therapeutic responses in patients with histologically disparate high-grade gliomas demonstrating chromosome 1p loss.
Journal of neurosurgery 2000;92(6):983-90.
2000: Sascha Weggen; Thomas A Bayer; Andreas von Deimling; Guido Reifenberger; Dietrich von Schweinitz; Otmar D Wiestler; Torsten Pietsch
Low frequency of SV40, JC and BK polyomavirus sequences in human medulloblastomas, meningiomas and ependymomas.
Brain pathology (Zurich, Switzerland) 2000;10(1):85-92.
1999: Andreas von Deimling; J Larson; Ruth Wellenreuther; AP Stangl; V van Velthoven; Ronald E Warnick; J Tew; G Balko; A G Menon
Clonal origin of recurrent meningiomas.
Brain pathology (Zurich, Switzerland) 1999;9(4):645-50.
1999: Christoph Schmutte; Gregory Tombline; Kerstin Rhiem; MM Sadoff; Rita K Schmutzler; Andreas von Deimling; Richard Fishel
Characterization of the human Rad51 genomic locus and examination of tumors with 15q14-15 loss of heterozygosity (LOH).
Cancer research 1999;59(18):4564-9.
1999: Yasushi Ino; J S Silver; L Blazejewski; Ryo Nishikawa; Masao Matsutani; Andreas von Deimling; David N Louis
Common regions of deletion on chromosome 22q12.3-q13.1 and 22q13.2 in human astrocytomas appear related to malignancy grade.
Journal of neuropathology and experimental neurology 1999;58(8):881-5.
1999: C Ebert; M von Haken; Birgit Meyer-Puttlitz; Otmar D Wiestler; Guido Reifenberger; Torsten Pietsch; Andreas von Deimling
Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas.
The American journal of pathology 1999;155(2):627-32.
1999: Matthias C Schmidt; R T Henke; AP Stangl; Birgit Meyer-Puttlitz; Birgit Stoffel-Wagner; Johannes Schramm; Andreas von Deimling
Analysis of the MEN1 gene in sporadic pituitary adenomas.
The Journal of pathology 1999;188(2):168-73.
1999: N Peters; Andreas Waha; Ruth Wellenreuther; R E Friedrich; V F Mautner; S Hoffmeyer; Doris Lenartz; Johannes Schramm; Otmar D Wiestler; Andreas von Deimling
Quantitative analysis of NF1 and OMGP gene transcripts in sporadic gliomas, sporadic meningiomas and neurofibromatosis type 1-associated plexiform neurofibromas.
Acta neuropathologica 1999;97(6):547-51.
1999: D Freihoff; A Kempe; B Beste; Barbara Wappenschmidt; E Kreyer; Y Hayashi; Alfons Meindl; Dieter Krebs; Otmar D Wiestler; Andreas von Deimling; Rita K Schmutzler
Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas.
British journal of cancer 1999;79(5-6):754-8.
1999: M B Müller; Matthias C Schmidt; O Schmidt; Y Hayashi; B Rollbrocker; Andreas Waha; Rolf Fimmers; Benedikt Volk; P Warnke; Christoph Ostertag; Otmar D Wiestler; Andreas von Deimling
Molecular genetic analysis as a tool for evaluating stereotactic biopsies of glioma specimens.
Journal of neuropathology and experimental neurology 1999;58(1):40-5.
1998: Andreas Waha; C Sturne; A Kessler; Arend Koch; E Kreyer; Rolf Fimmers; Otmar D Wiestler; Andreas von Deimling; Dieter Krebs; Rita K Schmutzler
Expression of the ATM gene is significantly reduced in sporadic breast carcinomas.
International journal of cancer. Journal international du cancer 1998;78(3):306-9.
1998: EM Duerr; B Rollbrocker; Y Hayashi; N Peters; Birgit Meyer-Puttlitz; David N Louis; Johannes Schramm; Otmar D Wiestler; R Parsons; C Eng; Andreas von Deimling
PTEN mutations in gliomas and glioneuronal tumors.
Oncogene 1998;16(17):2259-64.
1998: N Peters; Ruth Wellenreuther; B Rollbrocker; Y Hayashi; Birgit Meyer-Puttlitz; EM Duerr; Doris Lenartz; D J Marsh; Johannes Schramm; Otmar D Wiestler; R Parsons; C Eng; Andreas von Deimling
Analysis of the PTEN gene in human meningiomas.
Neuropathology and applied neurobiology 1998;24(1):3-8.
1998: R Przkora; Peter Falkai; Andreas von Deimling; Otmar D Wiestler; Margot Albus; Marcella Rietschel; Wolfgang Maier; Thomas A Bayer
Analysis of a polymorphism in the tuberous sclerosis (TSC2) gene does not predispose to schizophrenia.
European archives of psychiatry and clinical neuroscience 1998;248(6):314-5.
1998: Andreas Waha; Matthias Watzka; A Koch; Torsten Pietsch; R Przkora; N Peters; Otmar D Wiestler; Andreas von Deimling
A rapid and sensitive protocol for competitive reverse transcriptase (cRT) PCR analysis of cellular genes.
Brain pathology (Zurich, Switzerland) 1998;8(1):13-8.
1997: Ruth Wellenreuther; Andreas Waha; Y Vogel; Doris Lenartz; Johannes Schramm; Otmar D Wiestler; Andreas von Deimling
Quantitative analysis of neurofibromatosis type 2 gene transcripts in meningiomas supports the concept of distinct molecular variants.
Laboratory investigation; a journal of technical methods and pathology 1997;77(6):601-6.
1997: D Maintz; K Fiedler; J Koopmann; B Rollbrocker; S Nechev; Doris Lenartz; AP Stangl; David N Louis; Johannes Schramm; Otmar D Wiestler; Andreas von Deimling
Molecular genetic evidence for subtypes of oligoastrocytomas.
Journal of neuropathology and experimental neurology 1997;56(10):1098-104.
1997: Jan Mollenhauer; Stefan Wiemann; Wolfram Scheurlen; Bernhard Korn; Y Hayashi; KK Wilgenbus; Andreas von Deimling; Annemarie Poustka
DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours.
Nature genetics 1997;17(1):32-9.
1997: Birgit Meyer-Puttlitz; Y Hayashi; Andreas Waha; B Rollbrocker; J Boström; Otmar D Wiestler; David N Louis; Guido Reifenberger; Andreas von Deimling
Molecular genetic analysis of giant cell glioblastomas.
The American journal of pathology 1997;151(3):853-7.
1997: Y Hayashi; K Ueki; Andreas Waha; Otmar D Wiestler; David N Louis; Andreas von Deimling
Association of EGFR gene amplification and CDKN2 (p16/MTS1) gene deletion in glioblastoma multiforme.
Brain pathology (Zurich, Switzerland) 1997;7(3):871-5.
1997: Michael Platten; Birgit Meyer-Puttlitz; Ingmar Blümcke; Andreas Waha; HK Wolf; Markus M Nöthen; David N Louis; J R Sampson; Andreas von Deimling
A novel splice site associated polymorphism in the tuberous sclerosis 2 (TSC2) gene may predispose to the development of sporadic gangliogliomas.
Journal of neuropathology and experimental neurology 1997;56(7):806-10.
1997: Rita K Schmutzler; Erhard Bierhoff; T Werkhausen; Rolf Fimmers; Paul Speiser; Ernst Kubista; Dieter Krebs; Robert Zeillinger; Otmar D Wiestler; Andreas von Deimling
Genomic deletions in the BRCA1, BRCA2 and TP53 regions associate with low expression of the estrogen receptor in sporadic breast carcinoma.
International journal of cancer. Journal international du cancer 1997;74(3):322-5.
1997: Torsten Pietsch; Andreas Waha; Arend Koch; J Kraus; Steffen Albrecht; Jörg-Christian Tonn; Niels Sörensen; Frank Berthold; B Henk; N Schmandt; HK Wolf; Andreas von Deimling; Brandon J Wainwright; G Chenevix-Trench; Otmar D Wiestler; Carol Wicking
Medulloblastomas of the desmoplastic variant carry mutations of the human homologue of Drosophila patched.
Cancer research 1997;57(11):2085-8.
1997: AP Stangl; Ruth Wellenreuther; Doris Lenartz; J A Kraus; A G Menon; Johannes Schramm; Otmar D Wiestler; Andreas von Deimling
Clonality of multiple meningiomas.
Journal of neurosurgery 1997;86(5):853-8.
1997: Matthias Watzka; Andreas Waha; A Koch; Rita K Schmutzler; Frank Bidlingmaier; Andreas von Deimling; Dietrich Klingmüller; Birgit Stoffel-Wagner
An optimized protocol for mRNA quantification using nested competitive RT-PCR.
Biochemical and biophysical research communications 1997;231(3):813-7.
1997: Torsten Pietsch; Markus M Valter; HK Wolf; Andreas von Deimling; H J Huang; W K Cavenee; Otmar D Wiestler
Expression and distribution of vascular endothelial growth factor protein in human brain tumors.
Acta neuropathologica 1997;93(2):109-17.
1997: HK Wolf; Sabine Normann; A J Green; I von Bakel; Ingmar Blümcke; Torsten Pietsch; Otmar D Wiestler; Andreas von Deimling
Tuberous sclerosis-like lesions in epileptogenic human neocortex lack allelic loss at the TSC1 and TSC2 regions.
Acta neuropathologica 1997;93(1):93-6.
1996: Andreas Waha; A Baumann; HK Wolf; Rolf Fimmers; J Neumann; D Kindermann; K Astrahantseff; Ingmar Blümcke; Andreas von Deimling; U Schlegel
Lack of prognostic relevance of alterations in the epidermal growth factor receptor-transforming growth factor-alpha pathway in human astrocytic gliomas.
Journal of neurosurgery 1996;85(4):634-41.
1996: Rita K Schmutzler; Rolf Fimmers; Erhard Bierhoff; B Lohmar; A Homann; Paul Speiser; Ernst Kubista; K Jaeger; Dieter Krebs; Robert Zeillinger; Otmar D Wiestler; Andreas von Deimling
Association of allelic losses on human chromosomal arms 11Q and 16Q in sporadic breast cancer.
International journal of cancer. Journal international du cancer 1996;69(4):307-11.
1996: M Simon; A J Kokkino; Ronald E Warnick; J M Tew; Andreas von Deimling; Anil G Menon
Role of genomic instability in meningioma progression.
Genes, chromosomes & cancer 1996;16(4):265-9.
1996: J A Kraus; Arend Koch; Steffen Albrecht; Andreas von Deimling; Otmar D Wiestler; Torsten Pietsch
Loss of heterozygosity at locus F13B on chromosome 1q in human medulloblastoma.
International journal of cancer. Journal international du cancer 1996;67(1):11-5.
1996: B Rollbrocker; Andreas Waha; David N Louis; Otmar D Wiestler; Andreas von Deimling
Amplification of the cyclin-dependent kinase 4 (CDK4) gene is associated with high cdk4 protein levels in glioblastoma multiforme.
Acta neuropathologica 1996;92(1):70-4.
1996: Andreas Waha; B Rollbrocker; Otmar D Wiestler; Andreas von Deimling
A polymerase chain reaction-based assay for the rapid detection of gene amplification in human tumors.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 1996;5(2):147-50.
1996: W Wick; I Petersen; Rita K Schmutzler; B Wolfarth; Doris Lenartz; Erhard Bierhoff; J Hümmerich; D J Müller; AP Stangl; Johannes Schramm; Otmar D Wiestler; Andreas von Deimling
Evidence for a novel tumor suppressor gene on chromosome 15 associated with progression to a metastatic stage in breast cancer.
Oncogene 1996;12(5):973-8.
1996: M Hermanson; Keiko Funa; J Koopmann; D Maintz; Andreas Waha; Bengt Westermark; Carl-Henrik Heldin; Otmar D Wiestler; David N Louis; Andreas von Deimling; Monica Nistér
Association of loss of heterozygosity on chromosome 17p with high platelet-derived growth factor alpha receptor expression in human malignant gliomas.
Cancer research 1996;56(1):164-71.
1995: Andreas von Deimling; David N Louis; Otmar D Wiestler
Molecular pathways in the formation of gliomas.
Glia 1995;15(3):328-38.
1995: J Koopmann; D Maintz; S Schild; Johannes Schramm; David N Louis; Otmar D Wiestler; Andreas von Deimling
Multiple polymorphisms, but no mutations, in the WAF1/CIP1 gene in human brain tumours.
British journal of cancer 1995;72(5):1230-3.
1995: M Simon; Andreas von Deimling; J J Larson; Ruth Wellenreuther; P Kaskel; Andreas Waha; Ronald E Warnick; John M Tew; Anil G Menon
Allelic losses on chromosomes 14, 10, and 1 in atypical and malignant meningiomas: a genetic model of meningioma progression.
Cancer research 1995;55(20):4696-701.
1995: Ruth Wellenreuther; J A Kraus; Doris Lenartz; Anil G Menon; Johannes Schramm; David N Louis; Vijaya Ramesh; James Gusella; Otmar D Wiestler; Andreas von Deimling
Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma.
The American journal of pathology 1995;146(4):827-32.
1995: Andreas von Deimling; W Krone; Anil G Menon
Neurofibromatosis type 1: pathology, clinical features and molecular genetics.
Brain pathology (Zurich, Switzerland) 1995;5(2):153-62.
1995: J A Kraus; J Koopmann; P Kaskel; D Maintz; Sebastian Brandner; Johannes Schramm; David N Louis; Otmar D Wiestler; Andreas von Deimling
Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma.
Journal of neuropathology and experimental neurology 1995;54(1):91-5.
1995: Andreas von Deimling; J A Kraus; AP Stangl; Ruth Wellenreuther; Doris Lenartz; Johannes Schramm; David N Louis; Vijaya Ramesh; James Gusella; Otmar D Wiestler
Evidence for subarachnoid spread in the development of multiple meningiomas.
Brain pathology (Zurich, Switzerland) 1995;5(1):11-4.
1994: Steffen Albrecht; Dietrich von Schweinitz; Andreas Waha; J A Kraus; Andreas von Deimling; Torsten Pietsch
Loss of maternal alleles on chromosome arm 11p in hepatoblastoma.
Cancer research 1994;54(19):5041-4.
1994: Andreas von Deimling; J Nagel; B Bender; Doris Lenartz; Johannes Schramm; David N Louis; Otmar D Wiestler
Deletion mapping of chromosome 19 in human gliomas.
International journal of cancer. Journal international du cancer 1994;57(5):676-80.
1994: Andreas von Deimling; B Bender; R Jahnke; Andreas Waha; J Kraus; Steffen Albrecht; Ruth Wellenreuther; F Fassbender; J Nagel; Anil G Menon
Loci associated with malignant progression in astrocytomas: a candidate on chromosome 19q.
Cancer research 1994;54(6):1397-401.
1994: Andreas von Deimling; Steffen Albrecht; Otmar D Wiestler
[Progression-associated gene regions in astrocytomas: a candidate locus on chromosome 19q].
Verhandlungen der Deutschen Gesellschaft für Pathologie 1994;78():423-6.
1993: Andreas von Deimling; B Bender; D N Louis; Otmar D Wiestler
A rapid and non-radioactive PCR based assay for the detection of allelic loss in human gliomas.
Neuropathology and applied neurobiology 1993;19(6):524-9.